UAB Sees Opportunity with Precision Medicine
Precision medicine is changing the way doctors treat people with cancer. It’s an emerging field that is sometimes referred to as “personalized medicine.” That’s because treatments are tailored for specific patient traits. Many observers say UAB is particularly well-positioned to lead the targeted therapy front. That’s the subject of the cover article in Friday’s Birmingham Business Journal. Editor Ty West talked with WBHM’s Andrew Yeager.
Interview Highlights
What precision medicine is:
“In terms of cancer care, this is a very precise form of medicine that depends a lot on the human genome and the sequencing that’s happened in recent years. It basically allows you to develop a personalized plan of care based on a patient’s DNA. This is an area that’s grown exponentially really over the past five or six years and it is an area that many believe is going to be the next frontier in medicine overall, but particularly in terms of cancer care.”
Why UAB is positioned to ride this new technology:
“They’ve already kind of been at the forefront. They’ve made some strategic hires. If you look back over the past five or six years, they’ve hired some leading experts in precision medicine and genomic medicine, so that’s one reason. If think if you look at Alabama also and our health situation here in the state, experts have told us over the years that also creates some opportunities from some interesting clinical trials. A lot of groundbreaking cancer research can be done and that’s unfortunate for our community that we’re faced with some of those chronic health challenges, but it does create opportunities to change the world here in Birmingham.”
What the university plans to do:
“They want to do a $70 million genomic medicine building. That would be a wholesale renovation of an existing building. They’re approaching this like an economic development project, not like another building at UAB’s campus. They believe with a facility like this that could be kind of a leading global facility, it’ll make it easier to recruit researchers here. And every one of those researchers are kind of like a small business. They have staffs. They have million dollar budgets that are coming in. That’s bringing money into this community. But perhaps more importantly, it’s creating the opportunity to create more jobs down the road in terms of commercialization, in terms of spinning off some startups.”
Editorial note: UAB holds WBHM’s broadcast license, but WBHM’s news and business departments operate independently.
Alabama coal company sued for a home explosion is delinquent on dozens of penalties
Crimson Oak Grove Resources has been cited for 204 safety violations since the March 8 blast, many involving “significant and substantial” safety violations.
The United Auto Workers faces a key test in the South with upcoming vote at Alabama Mercedes plant
The United Auto Workers is aiming for a key victory at Mercedes-Benz in Alabama. More than 5,000 workers at the facility in Vance and nearby battery plant will vote this week on whether to join the UAW.
Gambling, ethics bills fall short as legislative session ends
Alabama lawmakers closed the books on this year’s regular legislative session Thursday. While Republican leaders passed many of their priority bills, perhaps the most talked about issue – gambling – died.
A look at what passed and failed in the 2024 legislative session
Alabama lawmakers have ended a 2024 legislative session that saw the Republican majority win approval for a number of their top priorities.
Q&A: Bobby Carter on leading Tiny Desk, his time at Jackson State, early career advice
Carter, a Jackson State alumnus, took over as the new series host and producer for NPR’s “Tiny Desk Concerts” series in April.
Alabama to begin working with a consulting company that’s under criminal investigation
McKinsey & Company, an international consulting business, will help the state of Alabama develop a new strategic economic growth plan. The company is undertaking that project, while also dealing with a probe into whether it engaged in a criminal conspiracy.
